Invesco’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $34.7M | Sell |
|
|||||
|
2023
Q1 | $36.7M | Buy |
|
|||||
|
2022
Q4 | $3.42M | Buy |
|
|||||
|
2022
Q3 | $681K | Buy |
|
|||||
|
2022
Q2 | $814K | Sell |
|
|||||
|
2022
Q1 | $1.84M | Sell |
|
|||||
|
2021
Q4 | $60.1M | Sell |
|
|||||
|
2021
Q3 | $346M | Buy |
|
|||||
|
2021
Q2 | $398M | Buy |
|
|||||
|
2021
Q1 | $205M | Buy |
|
|||||
|
2020
Q4 | $220M | Buy |
|
|||||
|
2020
Q3 | $54.8M | Buy |
|
|||||
|
2020
Q2 | $8.3M | Buy |
|
|||||
|
2020
Q1 | $231K | Sell |
|
|||||
|
2019
Q4 | $10.6M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.77M | Buy |
|
|||||
|
2019
Q1 | $1.59M | Buy |
|
|||||
|
2018
Q4 | $240K | Buy |
|